Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for ICUI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -20.14M
March 31, 2026 -11.21M
December 31, 2025 -18.39M
September 30, 2025 -30.03M
June 30, 2025 187.46M
March 31, 2025 -16.81M
December 31, 2024 -26.55M
September 30, 2024 -22.86M
June 30, 2024 -21.69M
March 31, 2024 -17.86M
December 31, 2023 -30.65M
September 30, 2023 -24.51M
June 30, 2023 -17.61M
March 31, 2023 -15.18M
December 31, 2022 -24.00M
September 30, 2022 -12.53M
June 30, 2022 -5.192M
March 31, 2022 -1.868B
December 31, 2021 -32.94M
September 30, 2021 -21.09M
June 30, 2021 -17.78M
March 31, 2021 -18.88M
December 31, 2020 -40.90M
September 30, 2020 -24.08M
June 30, 2020 -9.684M
Date Value
March 31, 2020 -23.47M
December 31, 2019 -101.00M
September 30, 2019 -23.90M
June 30, 2019 -31.48M
March 31, 2019 -10.51M
December 31, 2018 -19.08M
September 30, 2018 -45.00M
June 30, 2018 -24.27M
March 31, 2018 -15.02M
December 31, 2017 -29.61M
September 30, 2017 -50.96M
June 30, 2017 -12.40M
March 31, 2017 -173.90M
December 31, 2016 100.89M
September 30, 2016 -86.04M
June 30, 2016 0.869M
March 31, 2016 0.56M
December 31, 2015 -36.40M
September 30, 2015 -1.891M
June 30, 2015 7.037M
March 31, 2015 20.02M
December 31, 2014 3.401M
September 30, 2014 -1.823M
June 30, 2014 -11.33M
March 31, 2014 -12.00M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. -117.00M
Becton, Dickinson & Co. -228.00M
Boston Scientific Corp. -1.956B
Glaukos Corp. -5.306M
Medline, Inc. -461.00M